Trending Stock Alerts

SVA:CC

Quote

Short

News

Articles

Message Board

Sernova Biotherapeutics Inc. (TSXVC : SVA:CC ) News

News Releases

SVA:CC News Releases

June 17, 2026 07:00:00 am

GlobeNewswire

Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy

April 23, 2026 04:15:00 pm

TMX Newsfile

Sernova Biotherapeutics Announces Closing of Recently Approved Financings

April 09, 2026 07:00:00 am

TMX Newsfile

Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders

March 24, 2026 07:00:00 am

TMX Newsfile

Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing

March 04, 2026 07:00:00 am

TMX Newsfile

Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval

February 20, 2026 07:56:39 am

SeekingAlpha

Sernova to amend warrants, extend expiry, and cut exercise price

February 20, 2026 07:00:00 am

TMX Newsfile

Sernova Biotherapeutics Announces Warrant Amendments

December 16, 2025 12:00:04 pm

GlobeNewswire

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

November 13, 2025 07:00:00 am

Newsfile

Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts

October 01, 2025 07:00:00 am

Newsfile

Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account